Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Myocet and cyclophosphamide in older patients with metastatic breast cancer
NCT01120171Phase 2Terminated
- Sponsor
- Hellenic Oncology Research Group
- Start
- Sep 2009
- Primary completion
- May 2015
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of doxorubicin in breast cancer, sponsored by Hellenic Oncology Research Group. Started Sep 2009; status: terminated.
02
Drugs
doxorubicin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01120171.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01120171.